Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology”), a wholly-owned subsidiary of the company, received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration, involving the product: “KH813 injection”.

Zhitongcaijing · 06/30 11:41
Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology”), a wholly-owned subsidiary of the company, received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration, involving the product: “KH813 injection”.